KLC4
Kinesin light chain 4
Also known as: bA387M24.3, KLC4_HUMAN, KNSL8
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NSK0
- Gene
- KLC4
- Ensembl
- ENSG00000137171
- Chromosome
- 6
- Canonical length
- 619 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Mitochondria,Cytosol
OverviewNCBI Gene
Predicted to enable kinesin binding activity. Predicted to be involved in microtubule-based movement. Predicted to be located in microtubule. Predicted to be part of kinesin complex. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
619 residues, UniProt reviewed canonical sequence.
>Q9NSK0|KLC4
1 MSGLVLGQRD EPAGHRLSQE EILGSTRLVS QGLEALRSEH QAVLQSLSQT IECLQQGGHE
61 EGLVHEKARQ LRRSMENIEL GLSEAQVMLA LASHLSTVES EKQKLRAQVR RLCQENQWLR
121 DELAGTQQRL QRSEQAVAQL EEEKKHLEFL GQLRQYDEDG HTSEEKEGDA TKDSLDDLFP
181 NEEEEDPSNG LSRGQGATAA QQGGYEIPAR LRTLHNLVIQ YAAQGRYEVA VPLCKQALED
241 LERTSGRGHP DVATMLNILA LVYRDQNKYK EAAHLLNDAL SIRESTLGPD HPAVAATLNN
301 LAVLYGKRGK YKEAEPLCQR ALEIREKVLG TNHPDVAKQL NNLALLCQNQ GKYEAVERYY
361 QRALAIYEGQ LGPDNPNVAR TKNNLASCYL KQGKYAEAET LYKEILTRAH VQEFGSVDDD
421 HKPIWMHAEE REEMSKSRHH EGGTPYAEYG GWYKACKVSS PTVNTTLRNL GALYRRQGKL
481 EAAETLEECA LRSRRQGTDP ISQTKVAELL GESDGRRTSQ EGPGDSVKFE GGEDASVAVE
541 WSGDGSGTLQ RSGSLGKIRD VLRRSSELLV RKLQGTEPRP SSSNMKRAAS LNYLNQPSAA
601 PLQVSRGLSA STMDLSSSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KLC4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 87 nTPM
Expression across tissuesHPA
Tissue
- liver: 87 nTPM
- duodenum: 68 nTPM
- small intestine: 60 nTPM
- colon: 39 nTPM
- rectum: 32 nTPM
- cerebellum: 32 nTPM
Single-cell type
- enterocytes: 177 nCPM
- cardiomyocytes: 160 nCPM
- hepatocytes: 106 nCPM
- colonocytes: 104 nCPM
- retinal ganglion cells: 70 nCPM
- adipocytes: 66 nCPM
Immune cell
- plasmacytoid DC: 8.8 nTPM
- neutrophil: 6.6 nTPM
- NK-cell: 4.9 nTPM
- naive CD4 T-cell: 4.5 nTPM
- T-reg: 4.5 nTPM
- memory B-cell: 3.7 nTPM
Brain region
- cerebellum: 31 nTPM
- pons: 30 nTPM
- white matter: 29 nTPM
- cerebral cortex: 28 nTPM
- medulla oblongata: 27 nTPM
- thalamus: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KLC4.
Disease | AllUniProt
Conditions KLC4 is implicated in, by any mechanism.
- Neurodegeneration, early-childhood-onset, with retinitis pigmentosa, sensorineural hearing loss, and demyelinating peripheral neuropathy (CONDRHN) MIM:621129
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 121 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Early-childhood-onset neurodegeneration with retinitis pigmentosa, sensorineural hearing loss, and demyelinating peripheral neuropathy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.89
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KLC4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KLC4 as an antibody target. Whether an autoantibody or antibody against KLC4 could matter depends on whether native KLC4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KLC4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KLC4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...